Cargando…

Unilateral Erythema Nodosum following Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate Combination Therapy

Erythema nodosum is a septal panniculitis that typically presents as symmetric, tender nodules on the anterior aspects of bilateral lower extremities. Nearly half of cases are due to secondary causes, with oral contraceptive pills being the leading pharmaceutical cause. However, to our knowledge, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Michelle S., Fischer, Rob, Fournier, John B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826688/
https://www.ncbi.nlm.nih.gov/pubmed/27110414
http://dx.doi.org/10.1155/2016/5726416
_version_ 1782426364422389760
author Min, Michelle S.
Fischer, Rob
Fournier, John B.
author_facet Min, Michelle S.
Fischer, Rob
Fournier, John B.
author_sort Min, Michelle S.
collection PubMed
description Erythema nodosum is a septal panniculitis that typically presents as symmetric, tender nodules on the anterior aspects of bilateral lower extremities. Nearly half of cases are due to secondary causes, with oral contraceptive pills being the leading pharmaceutical cause. However, to our knowledge, there has yet to be a published association with norethindrone acetate, ethinyl estradiol, and ferrous fumarate. We report our experience with a 30-year-old woman who developed unilateral tender nodules within a month of starting 1 mg norethindrone acetate and 20 mcg ethinyl estradiol daily. Of note, she had previously taken oral contraceptives with the same estrogen agent but different progesterone, without problems. We conclude that systemically triggered erythema nodosum can present with lesions localized to one extremity. When a patient presents with tender, firm nodules, clinicians should consider the possibility of erythema nodosum and its triggers, such as oral contraceptives. Additionally, should a patient on hormonal therapy develop erythema nodosum, changing the progesterone agent may allow the patient to continue similar therapy without developing symptoms.
format Online
Article
Text
id pubmed-4826688
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-48266882016-04-24 Unilateral Erythema Nodosum following Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate Combination Therapy Min, Michelle S. Fischer, Rob Fournier, John B. Case Rep Obstet Gynecol Case Report Erythema nodosum is a septal panniculitis that typically presents as symmetric, tender nodules on the anterior aspects of bilateral lower extremities. Nearly half of cases are due to secondary causes, with oral contraceptive pills being the leading pharmaceutical cause. However, to our knowledge, there has yet to be a published association with norethindrone acetate, ethinyl estradiol, and ferrous fumarate. We report our experience with a 30-year-old woman who developed unilateral tender nodules within a month of starting 1 mg norethindrone acetate and 20 mcg ethinyl estradiol daily. Of note, she had previously taken oral contraceptives with the same estrogen agent but different progesterone, without problems. We conclude that systemically triggered erythema nodosum can present with lesions localized to one extremity. When a patient presents with tender, firm nodules, clinicians should consider the possibility of erythema nodosum and its triggers, such as oral contraceptives. Additionally, should a patient on hormonal therapy develop erythema nodosum, changing the progesterone agent may allow the patient to continue similar therapy without developing symptoms. Hindawi Publishing Corporation 2016 2016-03-27 /pmc/articles/PMC4826688/ /pubmed/27110414 http://dx.doi.org/10.1155/2016/5726416 Text en Copyright © 2016 Michelle S. Min et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Min, Michelle S.
Fischer, Rob
Fournier, John B.
Unilateral Erythema Nodosum following Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate Combination Therapy
title Unilateral Erythema Nodosum following Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate Combination Therapy
title_full Unilateral Erythema Nodosum following Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate Combination Therapy
title_fullStr Unilateral Erythema Nodosum following Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate Combination Therapy
title_full_unstemmed Unilateral Erythema Nodosum following Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate Combination Therapy
title_short Unilateral Erythema Nodosum following Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate Combination Therapy
title_sort unilateral erythema nodosum following norethindrone acetate, ethinyl estradiol, and ferrous fumarate combination therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826688/
https://www.ncbi.nlm.nih.gov/pubmed/27110414
http://dx.doi.org/10.1155/2016/5726416
work_keys_str_mv AT minmichelles unilateralerythemanodosumfollowingnorethindroneacetateethinylestradiolandferrousfumaratecombinationtherapy
AT fischerrob unilateralerythemanodosumfollowingnorethindroneacetateethinylestradiolandferrousfumaratecombinationtherapy
AT fournierjohnb unilateralerythemanodosumfollowingnorethindroneacetateethinylestradiolandferrousfumaratecombinationtherapy